Subscribe

Subscribe

Latest Content

Solar

Storage

Wind

Event Spotlight

BLOGS

DISTRIBUTECH+ RECAP: Energy Storage Utility Case Studies

Webcast

OPINION

RESOURCES

CLARION ENERGY MEDIA

POWER & ENERGY EVENT SERIES

Privacy Policy

Copyright © 2019 - 2021

Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Canaquest Medical Corp (OP: CANQF )

0.0215 -0.0684 (-76.08%)
Streaming Delayed Price Updated: 3:54 PM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25,345
Open 0.0221
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0899
Today's Range 0.0215 - 0.0900
52wk Range 0.0212 - 0.4399
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
New Leaders Of NY Cannabis Reg Body And Recent Industry Appointments You Need To Know About
Chris Alexander, the former head of the New York Office of Cannabis Management (OCM), resigned in May. Gov. Kathy Hochul first announced that Alexander's contract would not be renewed following its end... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players
Via ACCESSWIRE

Performance

YTD
-93.48%
-93.48%
1 Month
-76.08%
-76.08%
3 Month
-78.48%
-78.48%
6 Month
-90.65%
-90.65%
1 Year
-82.08%
-82.08%

More News

Read More
CANAQUEST Announces Award of European Cannabinoid Patent
Via ACCESSWIRE
CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program
Via ACCESSWIRE
CanaQuest and Neeka Health Sign Agreement to Conduct Clinical Studies with Mentanine(R)
Via ACCESSWIRE
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD
Via ACCESSWIRE
CanaQuest Achieves Statistically Significant Results in Reduction of Seizures for Epilepsy Compared to Standard CBD
Via iCrowdNewswire
CBD Combined With Essential Fatty Acids Is 40% More Efficient In Epilepsy Seizure Reduction Than Regular CBD, New Study
Via Benzinga
Canaquest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via WWW.CANAQUESTSTORE.COM, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD
Via ACCESSWIRE
The Week In Cannabis: PA, MD, Big Tobacco, GTI, Sundial, MedMen, Earnings, Financings And More
Via Benzinga
Topics Cannabis
Exposures Cannabis
CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health
From CanaQuest Medical Corp.
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property Product Safety
Cannabis Movers & Shakers: CanaQuest, Terra Tech, BioSteel, Halo Collective, Rolling Stone Culture Council, Australis
Via Benzinga
Topics Cannabis
Exposures Cannabis
CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications
From CanaQuest Medical Corp.
Via AccessWire
Topics Cannabis Initial Public Offering
Exposures Cannabis Securities Market
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.